Over the past three years, pharma has invested heavily in digital capabilities for market access—with varying degrees of impact and focus. There are many success stories, and those with less than successful endings offer valuable opportunities for the industry to learn and adapt. A few companies are particularly well positioned to continue pushing on to the next frontier of innovation, which inevitably includes both classical and gen AI. Guests from Pfizer and Amgen offer key insights on how their organizations are pushing the boundaries of what’s possible.
Watch this webinar to learn:
- Where pharma companies are successfully investing in digital capabilities
- What it takes to build and sustain these capabilities at scale
- What the value of these capabilities has been and how they’ve been measured
Add insights to your inbox
We’ll send you content you’ll want to read – and put to use.
